The following Organisations supported many of the works published in CANCER GENOMICS & PROTEOMICS, Volume 17, 2020. 90th Anniversary of Chulalongkorn University, Rachadapisek Sompote Fund, Bangkok, Thailand Asia University, Taichung, Taiwan, R.O.C. AstraZeneca plc, Cambridge, U.K. Atomic-bomb Survivors Hospital, Hiroshima, Japan Basic Science Research Program, National Research Foundation of Korea (nRF), Ministry of Science and […]
Reprints Order If reprints are required, please fill in the requested information on the REPRINT ORDER FORM, which accompanies the galley proofs. Reprints must be paid for in advance. The reprints are not to be sold. Please address requests for reprints to the Editorial Office (e-mail: journals@iiar-anticancer.org) with any specific requirement (color covers, shrink wrapping, […]
Special Issues of Cancer Genomics & Proteomics Publication of Conference Proceedings and Abstracts. Editorial Policy A special issue may be edited by one or more scientists (Guest Editors). The subject of a special issue should be within the scopes of the journal and should be selected from fields in which important advances have been made […]
This letter accompanies the proof sent to Authors Dear Sir/Madam: Enclosed are the galley proofs of your article for CANCER GENOMICS & PROTEOMICS. We would like to call your attention to the following: Please read thoroughly, correct, and return the proofs to the Editorial Office within 24 hours. Proofs should be returned by e-mail, fax […]
General Policy CANCER GENOMICS & PROTEOMICS (CGP) welcomes the submission of high quality original articles and reviews on all aspects of the application of genomic and proteomic technologies to experimental and clinical cancer research. The journal’s scientific spectrum includes: (a) molecular causes of carcinogenesis, cancer progression and metastasis; (b) structural and functional aspects of genes […]
Welcome to the Online Manuscript Submission and Tracking System for the journal CANCER GENOMICS & PROTEOMICS. Please read the Instructions for Authors before submitting your article. The principal aim of CANCER GENOMICS & PROTEOMICS is to provide prompt publication for high-quality articles and reviews on the application of genomic and proteomic technology to experimental and […]
A. Seth Editor-in-chief, Laboratory of Molecular Pathology, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada G. J. Delinasios Managing Editor and Executive Publisher, International Institute of Anticancer Research, Athens, Greece L.A. Aaltonen Department of Medical Genetics, University of Helsinki, Helsinki, Finland R. Abagyan The Scripps Research Institute, La Jolla, […]